Atomistry » Magnesium » PDB 4qh0-4qpm » 4qlv
Atomistry »
  Magnesium »
    PDB 4qh0-4qpm »
      4qlv »

Magnesium in PDB 4qlv: Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17

Enzymatic activity of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17

All present enzymatic activity of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17:
3.4.25.1;

Protein crystallography data

The structure of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17, PDB code: 4qlv was solved by G.De Bruin, E.Huber, B.Xin, E.Van Rooden, K.Al-Ayed, K.Kim, A.Kisselev, C.Driessen, G.Van Der Marel, M.Groll, H.Overkleeft, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 15.00 / 2.90
Space group P 1 21 1
Cell size a, b, c (Å), α, β, γ (°) 136.040, 300.380, 146.520, 90.00, 112.97, 90.00
R / Rfree (%) 18.4 / 20.9

Magnesium Binding Sites:

The binding sites of Magnesium atom in the Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17 (pdb code 4qlv). This binding sites where shown within 5.0 Angstroms radius around Magnesium atom.
In total 8 binding sites of Magnesium where determined in the Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17, PDB code: 4qlv:
Jump to Magnesium binding site number: 1; 2; 3; 4; 5; 6; 7; 8;

Magnesium binding site 1 out of 8 in 4qlv

Go back to Magnesium Binding Sites List in 4qlv
Magnesium binding site 1 out of 8 in the Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 1 of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17 within 5.0Å range:
probe atom residue distance (Å) B Occ
G:Mg301

b:63.4
occ:1.00
 O G:MET125 2.0 70.0 1.0
O G:TYR119 2.4 57.5 1.0
O G:ARG122 2.4 58.0 1.0
OG1 G:THR8 2.4 56.6 1.0
C G:MET125 3.3 64.0 1.0
CG2 G:THR8 3.4 45.5 1.0
CB G:THR8 3.5 47.5 1.0
C G:TYR119 3.5 58.8 1.0
C G:ARG122 3.6 61.5 1.0
O G:ALA123 3.7 63.0 1.0
CA G:ALA123 3.9 56.9 1.0
C G:ALA123 3.9 60.8 1.0
N G:MET125 4.1 59.0 1.0
N G:ALA123 4.2 60.0 1.0
N G:ARG126 4.2 56.9 1.0
CA G:MET125 4.2 64.7 1.0
CA G:TYR119 4.2 57.3 1.0
CA G:ARG126 4.3 55.5 1.0
N G:THR8 4.4 52.7 1.0
CA G:THR8 4.6 53.0 1.0
CB G:MET125 4.6 73.3 1.0
N G:THR120 4.6 55.5 1.0
CB G:TYR119 4.6 58.7 1.0
CD G:PRO127 4.7 41.6 1.0
N G:TYR124 4.7 65.7 1.0
N G:ARG122 4.7 58.2 1.0
C G:ARG126 4.8 55.2 1.0
CA G:ARG122 4.8 61.1 1.0
CA G:THR120 4.9 50.6 1.0
C G:THR120 4.9 52.5 1.0
N G:PRO127 5.0 49.3 1.0

Magnesium binding site 2 out of 8 in 4qlv

Go back to Magnesium Binding Sites List in 4qlv
Magnesium binding site 2 out of 8 in the Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 2 of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17 within 5.0Å range:
probe atom residue distance (Å) B Occ
I:Mg301

b:52.0
occ:1.00
 O I:ASP177 2.4 63.2 1.0
O I:SER180 2.6 49.9 1.0
O I:ALA174 2.8 53.9 1.0
C I:ASP177 3.6 62.6 1.0
OXT I:ASP204 3.7 67.2 1.0
C I:SER180 3.8 54.4 1.0
C I:ALA174 3.9 61.3 1.0
CA I:ALA178 4.3 58.6 1.0
CA I:ASP175 4.3 69.4 1.0
N I:ALA178 4.4 60.7 1.0
C I:ALA178 4.4 56.4 1.0
N I:ASP175 4.5 63.9 1.0
O I:ALA178 4.6 63.6 1.0
C I:ASP175 4.6 66.0 1.0
O I:ASP175 4.6 70.5 1.0
C I:ASP204 4.6 68.8 1.0
N I:ASP177 4.6 63.1 1.0
O I:ASP204 4.6 70.1 1.0
N I:SER180 4.6 50.1 1.0
CA I:ASP177 4.7 64.0 1.0
NH1 Y:ARG19 4.7 80.4 1.0
NH2 Y:ARG19 4.7 88.5 1.0
CA I:GLY181 4.7 57.5 1.0
N I:GLY181 4.7 56.0 1.0
CA I:SER180 4.8 53.3 1.0
N I:LEU179 4.9 49.5 1.0
OD1 I:ASP175 4.9 65.5 1.0
CA I:ALA174 5.0 61.2 1.0

Magnesium binding site 3 out of 8 in 4qlv

Go back to Magnesium Binding Sites List in 4qlv
Magnesium binding site 3 out of 8 in the Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 3 of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17 within 5.0Å range:
probe atom residue distance (Å) B Occ
K:Mg301

b:78.5
occ:1.00
 O W:ASP204 2.2 79.6 1.0
O K:ALA165 2.4 59.8 1.0
O K:ASP168 2.4 76.2 1.0
O K:SER171 2.9 66.5 1.0
C W:ASP204 3.0 78.7 1.0
C K:ASP168 3.3 71.4 1.0
O K:HIS166 3.5 56.0 1.0
CA W:ASP204 3.5 70.1 1.0
C K:ALA165 3.6 65.0 1.0
CA K:ALA169 3.6 63.7 1.0
N K:ALA169 3.8 70.2 1.0
C K:ALA169 3.9 64.7 1.0
O K:ALA169 3.9 62.8 1.0
C K:HIS166 4.0 60.3 1.0
OXT W:ASP204 4.0 82.8 1.0
CB W:ASP204 4.0 65.6 1.0
NH1 K:ARG19 4.1 92.4 1.0
C K:SER171 4.1 70.9 1.0
CA K:HIS166 4.4 61.9 1.0
N K:HIS166 4.4 64.7 1.0
N K:ASP168 4.4 64.8 1.0
CA K:ASP168 4.5 67.8 1.0
N K:SER171 4.5 66.2 1.0
C K:ARG167 4.6 61.3 1.0
CA K:ALA165 4.6 68.6 1.0
O K:ALA164 4.6 65.1 1.0
O K:ARG167 4.7 54.7 1.0
N K:ARG167 4.7 57.1 1.0
N K:TYR170 4.7 62.3 1.0
CZ K:ARG19 4.8 83.2 1.0
N W:ASP204 4.8 65.6 1.0
CA K:SER171 4.8 65.3 1.0
CB K:ALA169 5.0 55.4 1.0
NH2 K:ARG19 5.0 85.2 1.0

Magnesium binding site 4 out of 8 in 4qlv

Go back to Magnesium Binding Sites List in 4qlv
Magnesium binding site 4 out of 8 in the Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 4 of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17 within 5.0Å range:
probe atom residue distance (Å) B Occ
N:Mg201

b:68.1
occ:1.00
 O N:SER169 2.8 61.1 1.0
O N:ILE163 2.8 55.9 1.0
O N:ASP166 3.3 56.8 1.0
NH1 N:ARG19 3.6 61.6 1.0
CD1 a:LEU34 3.7 59.1 1.0
C N:SER169 3.9 58.8 1.0
C N:ILE163 3.9 56.8 1.0
CZ N:ARG19 4.1 58.4 1.0
CG2 N:ILE163 4.1 54.5 1.0
CA N:GLY167 4.2 49.8 1.0
NH2 N:ARG19 4.2 54.9 1.0
C N:ASP166 4.3 52.6 1.0
CA N:GLY170 4.3 64.6 1.0
O N:GLY167 4.4 48.4 1.0
N N:GLY170 4.6 60.2 1.0
C N:GLY167 4.6 50.4 1.0
N N:GLY167 4.6 51.0 1.0
CA N:ILE163 4.7 55.8 1.0
O N:LYS164 4.9 60.4 1.0
N N:LYS164 4.9 63.5 1.0
CG a:LEU34 5.0 61.7 1.0
CA N:SER169 5.0 53.0 1.0
N N:SER169 5.0 54.8 1.0

Magnesium binding site 5 out of 8 in 4qlv

Go back to Magnesium Binding Sites List in 4qlv
Magnesium binding site 5 out of 8 in the Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 5 of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17 within 5.0Å range:
probe atom residue distance (Å) B Occ
N:Mg202

b:78.3
occ:1.00
 OE1 H:GLN91 2.9 80.8 1.0
OD1 N:ASP51 3.2 50.4 1.0
O N:ASN92 3.3 68.9 1.0
OD2 N:ASP51 3.6 59.0 1.0
CG N:ASP51 3.8 58.0 1.0
CD H:GLN91 3.9 85.7 1.0
NE2 H:GLN91 4.1 94.1 1.0
C N:ASN92 4.5 67.5 1.0

Magnesium binding site 6 out of 8 in 4qlv

Go back to Magnesium Binding Sites List in 4qlv
Magnesium binding site 6 out of 8 in the Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 6 of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17 within 5.0Å range:
probe atom residue distance (Å) B Occ
V:Mg301

b:68.4
occ:1.00
 O V:ASP166 2.3 66.1 1.0
O V:ILE163 2.5 64.6 1.0
OXT L:ASP222 2.5 72.2 1.0
O V:TRP164 2.9 68.4 1.0
C V:ASP166 3.0 65.4 1.0
C L:ASP222 3.1 75.2 1.0
C V:TRP164 3.3 65.5 1.0
N V:ASP166 3.3 57.4 1.0
C V:ILE163 3.5 67.9 1.0
O V:SER169 3.6 69.3 1.0
N V:LEU167 3.7 69.6 1.0
O L:ASP222 3.7 74.7 1.0
CA V:ASP166 3.8 57.5 1.0
N V:ASN165 3.9 64.4 1.0
CA L:ASP222 3.9 78.5 1.0
C V:ASN165 3.9 60.2 1.0
CA V:TRP164 3.9 63.7 1.0
CA V:LEU167 3.9 67.9 1.0
O V:GLY162 4.0 67.5 1.0
N V:TRP164 4.1 65.7 1.0
CA V:ASN165 4.3 61.4 1.0
CD2 V:LEU167 4.5 61.5 1.0
O L:ARG221 4.5 65.8 1.0
CD1 L:ILE35 4.6 72.8 1.0
O V:ASN165 4.6 58.7 1.0
CA V:ILE163 4.7 69.7 1.0
CB L:ASP222 4.8 81.7 1.0
C V:SER169 4.8 66.8 1.0
NH1 V:ARG19 4.8 0.5 1.0
C V:LEU167 4.8 64.0 1.0
CB V:ASP166 4.8 56.7 1.0
N L:ASP222 5.0 76.9 1.0

Magnesium binding site 7 out of 8 in 4qlv

Go back to Magnesium Binding Sites List in 4qlv
Magnesium binding site 7 out of 8 in the Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 7 of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17 within 5.0Å range:
probe atom residue distance (Å) B Occ
Y:Mg301

b:57.8
occ:1.00
 O Y:ASP168 2.2 58.0 1.0
O I:ASP204 2.4 70.1 1.0
O Y:ALA165 2.5 53.8 1.0
O Y:SER171 2.8 66.7 1.0
C Y:ASP168 3.1 56.1 1.0
C I:ASP204 3.3 68.8 1.0
CA Y:ALA169 3.4 49.9 1.0
O Y:HIS166 3.6 58.1 1.0
N Y:ALA169 3.6 54.5 1.0
C Y:ALA165 3.6 50.9 1.0
C Y:ALA169 3.7 52.9 1.0
CA I:ASP204 3.8 65.6 1.0
O Y:ALA169 3.8 55.9 1.0
C Y:SER171 4.0 67.1 1.0
C Y:HIS166 4.1 55.7 1.0
NH1 Y:ARG19 4.1 80.4 1.0
CB I:ASP204 4.2 62.9 1.0
OXT I:ASP204 4.2 67.2 1.0
N Y:SER171 4.3 60.2 1.0
CA Y:ASP168 4.3 54.3 1.0
N Y:ASP168 4.3 58.4 1.0
N Y:HIS166 4.5 49.4 1.0
C Y:ARG167 4.5 59.2 1.0
N Y:TYR170 4.5 52.5 1.0
CA Y:HIS166 4.5 51.9 1.0
O Y:ALA164 4.6 65.0 1.0
CA Y:ALA165 4.6 52.3 1.0
O Y:ARG167 4.6 55.4 1.0
CA Y:SER171 4.7 61.9 1.0
N Y:ARG167 4.8 54.4 1.0
CZ Y:ARG19 4.8 78.7 1.0
CB Y:ALA169 4.8 48.2 1.0

Magnesium binding site 8 out of 8 in 4qlv

Go back to Magnesium Binding Sites List in 4qlv
Magnesium binding site 8 out of 8 in the Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 8 of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17 within 5.0Å range:
probe atom residue distance (Å) B Occ
Z:Mg301

b:69.5
occ:1.00
 O Z:VAL198 2.7 63.9 1.0
O Z:THR192 2.8 82.6 1.0
O Z:HIS195 2.8 63.2 1.0
NH2 Z:ARG28 3.6 69.8 1.0
O Z:ASP222 3.8 72.0 1.0
C Z:VAL198 3.8 67.5 1.0
C Z:THR192 3.8 74.1 1.0
C Z:HIS195 3.8 67.6 1.0
O Z:ILE196 3.9 77.7 1.0
CA Z:ILE196 3.9 69.5 1.0
CG2 Z:THR192 4.1 69.7 1.0
C Z:ILE196 4.1 71.9 1.0
NH2 H:ARG19 4.1 76.4 1.0
CA Z:THR192 4.2 71.4 1.0
OD1 Z:ASP222 4.3 74.6 1.0
N Z:ILE196 4.3 68.3 1.0
N Z:VAL198 4.5 67.6 1.0
C Z:ASP222 4.7 78.3 1.0
CA Z:VAL198 4.7 66.5 1.0
N Z:GLY199 4.7 64.3 1.0
CB Z:THR192 4.8 72.2 1.0
CA Z:GLY199 4.8 61.9 1.0
CZ Z:ARG28 4.8 70.3 1.0
NH1 H:ARG19 4.8 75.5 1.0
CZ H:ARG19 4.9 73.2 1.0
N Z:GLN197 4.9 71.2 1.0
N Z:HIS195 5.0 68.4 1.0

Reference:

G.De Bruin, E.M.Huber, B.T.Xin, E.J.Van Rooden, K.Al-Ayed, K.B.Kim, A.F.Kisselev, C.Driessen, M.Van Der Stelt, G.A.Van Der Marel, M.Groll, H.S.Overkleeft. Structure-Based Design of Beta 1I or Beta 5I Specific Inhibitors of Human Immunoproteasomes J.Med.Chem. V. 57 6197 2014.
ISSN: ISSN 0022-2623
PubMed: 25006746
DOI: 10.1021/JM500716S
Page generated: Tue Aug 20 02:05:45 2024

Last articles

Zn in 9JYW
Zn in 9IR4
Zn in 9IR3
Zn in 9GMX
Zn in 9GMW
Zn in 9JEJ
Zn in 9ERF
Zn in 9ERE
Zn in 9EGV
Zn in 9EGW
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy